SPX4,274.04-31.16 -0.72%
DIA340.20-1.54 -0.45%
IXIC12,938.12-164.43 -1.25%

BRIEF-Cspc Pharmaceutical Says Docetaxel For Injection (Albumin-Bound) Granted Orphan-Drug Designation

BRIEF-Cspc Pharmaceutical Says Docetaxel For Injection (Albumin-Bound) Granted Orphan-Drug Designation

Reuters · 07/28/2022 07:24
BRIEF-Cspc Pharmaceutical Says Docetaxel For Injection (Albumin-Bound) Granted Orphan-Drug Designation

- CSPC Pharmaceutical CHPTY:

  • DOCETAXEL FOR INJECTION (ALBUMIN-BOUND) WAS GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FOOD AND DRUG ADMINISTRATION



Further company coverage: CHPTY


((Reuters.Briefs@thomsonreuters.com;))